The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 30, 2014

Filed:

Aug. 04, 2010
Applicants:

Larry J. Anderson, Atlanta, GA (US);

Lia M. Haynes, Lithonia, GA (US);

Ralph A. Tripp, Decatur, GA (US);

Inventors:

Larry J. Anderson, Atlanta, GA (US);

Lia M. Haynes, Lithonia, GA (US);

Ralph A. Tripp, Decatur, GA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/155 (2006.01); C07K 14/135 (2006.01); C07K 14/005 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/135 (2013.01); A61K 39/155 (2013.01); C12N 2760/18522 (2013.01); C07K 14/005 (2013.01); A61K 2039/545 (2013.01); C12N 2760/18534 (2013.01); A61K 2039/555 (2013.01);
Abstract

Immunogenic polypeptides corresponding to one or more RSV G glycoproteins, or analogues thereof, are provided as components of vaccines. The inventive compositions are useful as both a prophylactic and therapeutic for the prevention and treatment of RSV infections and associated pulmonary or other diseases. The inventive immunogens include regions of the RSV G protein, specifically, amino acid residues 164-176 of RSV G A2 protein or analogues thereof. This inventive immunogen is operable alone or in combination with other polypeptides such as the RSV G protein amino acid residues 155-206, or other vaccines such as live RSV vaccines, or inactivated RSV vaccines or immunogenic analogues thereof.


Find Patent Forward Citations

Loading…